Department of Urology, Herlev and Gentofte Hospital, Copenhagen, Denmark.
Department of Urology, Vestfold Hospital Trust, Toensberg, Oslo, Norway.
BMC Urol. 2024 Jun 25;24(1):132. doi: 10.1186/s12894-024-01515-7.
Upper tract urothelial carcinoma (UTUC) is a rare malignancy, with typically only few new cases annually per urological department. Adherence to European association of urology (EAU) guidelines on UTUC in the Nordic countries is unknown. The objective of this survey was to examine the implementation of EAU guidelines, the perioperative management and organization of the treatment of UTUC in the Nordic countries.
The electronic survey was distributed to 93 hospitals in the Nordic countries performing radical nephroureterectomy (NU). The survey consisted of 57 main questions and data was collected between December 1st, 2021 and April 23rd, 2022.
Overall response rate was 47/93 (67%) with a completion rate of 98%. Five out of the 6 examined subjects on diagnostic practice are applied by ≥ 72% of the participating centers. NU as treatment for high-risk UTUC is performed by 37/47 (79%), and 91% include a bladder cuff excision.
Adherence to EAU guidelines is high on diagnostic practice in the Nordic countries, whereas disease management is less coherent.
上尿路尿路上皮癌(UTUC)是一种罕见的恶性肿瘤,每个泌尿外科每年通常只有少数新病例。北欧国家对欧洲泌尿外科学会(EAU)关于 UTUC 的指南的遵循情况尚不清楚。本次调查的目的是检查北欧国家 EAU 指南的实施情况、UTUC 的围手术期管理和治疗组织情况。
这项电子调查分发给了北欧国家的 93 家进行根治性肾输尿管切除术(NU)的医院。该调查包括 57 个主要问题,数据收集时间为 2021 年 12 月 1 日至 2022 年 4 月 23 日。
总体回复率为 47/93(67%),完成率为 98%。在接受检查的 6 项诊断实践中有 5 项被 67%以上的参与中心采用。37/47(79%)的高危 UTUC 患者接受了 NU 治疗,91%的患者包括膀胱袖口切除术。
北欧国家在诊断实践方面对 EAU 指南的遵循率较高,而疾病管理的一致性则较差。